KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Gains from Investment Securities (2017 - 2026)

Staar Surgical (STAA) has disclosed Gains from Investment Securities for 15 consecutive years, with $121000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 188.1% year-over-year to $121000.0, compared with a TTM value of $121000.0 through Sep 2025, down 93.82%, and an annual FY2026 reading of $2.0 million, down 27.81% over the prior year.
  • Gains from Investment Securities was $121000.0 for Q3 2025 at Staar Surgical, down from $433000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.4 million in Q1 2021 and bottomed at $7000.0 in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $982125.0, with a median of $286500.0 recorded in 2025.
  • The sharpest move saw Gains from Investment Securities soared 26314.29% in 2023, then plummeted 95.51% in 2024.
  • Year by year, Gains from Investment Securities stood at $2.4 million in 2021, then rose by 1.4% to $2.5 million in 2022, then rose by 6.52% to $2.6 million in 2023, then plummeted by 47.49% to $1.4 million in 2024, then crashed by 91.24% to $121000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for STAA at $121000.0 in Q3 2025, $433000.0 in Q2 2025, and $140000.0 in Q1 2025.